A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages

Thomas B Huffaker1, H Atakan Ekiz1, Cindy Barba1

  • 1Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT, USA.

Insights

Interferon gamma (IFNγ) activates STAT1 to regulate NAMPT enzyme, influencing tumor-associated macrophage metabolism and antitumor responses. Disabling this pathway increases tumor growth, highlighting NAMPT

Area of Science:

  • Immunology
  • Cancer Biology
  • Metabolic Regulation

Background:

  • Tumor-associated macrophage (TAM) function is dictated by their metabolic state, influenced by the tumor microenvironment.
  • Signals programming TAM metabolism are not fully understood, limiting therapeutic strategies.

Purpose of the Study:

  • To investigate the role of NAMPT (NAD salvage synthesis enzyme) as a target of STAT1 in regulating TAM metabolism.
  • To explore the impact of NAMPT activity on macrophage polarization and antitumor immunity.

Main Methods:

  • Identified STAT1 binding to the Nampt-Regulatory Element-1 (NRE1) in the Nampt gene.
  • Utilized genetic disruption of NRE1 and pharmacological NAMPT inhibition.
  • Employed single-cell RNA sequencing (scRNAseq) in a novel NRE1-deficient mouse model of melanoma.

Main Results:

  • STAT1-mediated regulation of NAMPT impacts M1 gene expression via glycolytic processes.
  • NRE1 deficiency in myeloid and APC populations reduced Nampt and inflammatory gene expression.
  • Targeted ablation of NRE1 in macrophages led to increased tumor burden in vivo.

Conclusions:

  • IFNγ and STAT1 induce NAMPT, a key regulator of TAM metabolic programming and function.
  • NAMPT activity is crucial for effective antitumor responses mediated by TAMs.
  • Elevated NAMPT expression correlates with IFNγ response and improved melanoma patient survival.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K